NRZ
Neurizer Ltd
🇦🇺 ASX
🧪 CHEMICALS
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
-19.76%
Annual Growth
5 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
17
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
NeuRizer Ltd. engages in the development of NeuRizer Urea Project (NRUP). The company is headquartered in Adelaide, South Australia. The company went IPO on 2005-03-17. The firm is focused on the development of NeuRizer Urea Project (NRUP). The NRUP project is located in South Australia, approximately 550 kilometers north of Adelaide. The NRUP is a fully integrated urea production facility in Australia, with all inputs (gas, power, and carbon di oxide) for low carbon urea production on-site. The NRUP project delivers nitrogen-based fertilizer supply to local and export agriculture markets. The company uses in-situ gasification to produce syngas from the deep Leigh Creek coal seams, and use this syngas to produce urea, a commonly used fertilizer. The firm produces approximately one million tons per annum (Mtpa) of urea fertilizer with the potential to increase to two Mtpa.
📈 Performance
Price History
-93.33%
1M
1Y
10Y
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
N/A
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.00
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NRZ
17
📊 Total Capital Earnings
$23K
🔃 Average investment frequency
33 weeks
💵 Average investment amount
$1,335
⏰ Last time a customer invested in NRZ
136 days
NRZ investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
12%
50k - 100k
47%
Less than 50k
41%
👶 Age of investors
18 - 25
26 - 34
53%
35 - 90
41%
🙋 Legal gender of investors
Female
35%
Male
65%
Pearlers who invest in NRZ also invest in...
NRZR
NeuRizer Ltd. engages in the development of NeuRizer Urea Project (NRUP). The company is headquartered in Adelaide, South Australia. The company went IPO on 2005-03-17. The firm is the carbon neutral producer of urea fertilizer. The firm is focused on the development of NeuRizer Urea Project (NRUP). The NRUP project is located in South Australia, approximately 550 kilometers north of Adelaide. The NRUP is a fully integrated urea production facility in Australia, with all inputs (gas, power, and carbon di oxide) for low carbon urea production on-site. The NRUP project delivers nitrogen-based fertilizer supply to local and export agriculture markets. The company uses in-situ gasification to produce syngas from the deep Leigh Creek coal seams, and use this syngas to produce urea, a commonly used fertiliser. The firm produces approximately one million tons per annum (Mtpa) of urea fertilizer with the potential to increase to two Mtpa.
📊 Share price
$0.00 AUD
NULL STOCK
VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
4.35%
📊 Share price
$104.33 AUD
⛳️ DIVERSIFIED
🧱 MATERIALS
💸 FINANCIALS
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
🙌 Performance (5Yr p.a)
13.23%
📊 Share price
$134.96 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
ETHI.AX was created on 2017-01-05 by BetaShares. The fund's investment portfolio concentrates primarily on total market equity. The fund aims to track the performance of an index (before fees and expenses) that includes a portfolio of large global stocks identified as Climate Leaders that have also passed screens to exclude companies with direct or significant exposure to fossil fuels or engaged in activities deemed inconsistent with responsible investment considerations.
🙌 Performance (5Yr p.a)
13.22%
📊 Share price
$15.78 AUD
🌏 GLOBAL
🤖 TECHNOLOGY
⛳️ DIVERSIFIED
📈 HIGH PRICE GROWTH
Weebit Nano Ltd. engages in developing and commercializing silicon oxide and Resistive Random-Access Memory technology. The company is headquartered in Melbourne, Victoria. The company went IPO on 2010-12-21. The Company’s Resistive RAM (ReRAM) addresses the growing need for higher performance and lower power non-volatile memory (NVM) solutions in a range of new electronic products, such as Internet of Things (IoT) devices, smartphones, robotics, autonomous vehicles, fifth generation (5G) communications and artificial intelligence. Its ReRAM technology is based on fab-friendly materials and can be easily integrated with existing flows and processes. The firm is creating ReRAM IP that customers can embed in their system-on-chip (SoC) designs. The company is also developing discrete (stand-alone) memory technology, targeting storage class memory, persistent memory and NOR flash replacement.
🙌 Performance (5Yr p.a)
124.19%
📊 Share price
$2.91 AUD
🤖 TECHNOLOGY
Want more shares? Try these...
Neuroscientific Biopharmaceuticals Ltd. engages in researching and developing novel peptide-based pharmaceutical products. The firm's product portfolio includes EmtinB, a therapeutic peptide initially targeting Alzheimer's disease and glaucoma, as well as other Emtin peptides (EmtinAc, EmtinAn, and EmtinBn), which have demonstrated similar therapeutic potential as EmtinB. EmtinB is a peptide-based compound that binds to surface-based cell receptors from the LDLR family, activating intracellular signalling pathways that stimulate neuroprotection, neuroregeneration and modulate neuroinflammation. EmtinB is modelled on a specific active domain of the complex human protein called Metallothionein-IIA, which is produced as part of the human body's innate immune response to cell injury.
🙌 Performance (5Yr p.a)
-17.26%
📊 Share price
$0.04 AUD
🧬 BIOTECHNOLOGY
Noronex Ltd. engages in exploration of mineral deposits projects in Australia and overseas. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2017-11-15. Its exploration package in Namibia covers 8,700 square kilometers (km2) with 3,500 kilometers (km) of applications in place on the prospective but relatively underexplored Kalahari Copper Belt which runs from central Namibia to northern Botswana. The tenements contain 300 km of strike length targeting the key NPF-D’Kar formation contact point where copper deposits occur in the Kalahari Copper Belt. Its Namibian exploration program is on the Witvlei, Snowball and Humpback Projects. The Snowball project lies to the east along a strike from Witvlei into the mineralized NPF-Eskadron Formation. The Snowball project is 30 km to the north-east of its existing Witvlei Copper Project. The company also has an agreement to acquire an 80 % interest in the Uranium Belt Project (EPL 6776), which covers 7,000 hectares and is located over three km north of the Etango project.
🙌 Performance (5Yr p.a)
-14.67%
📊 Share price
$0.01 AUD
⛏️ MINING
